CIT-013 low dose: Clinical Trials

1 trial of CIT-013 low dose, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow this drug Literature Review of CIT-013 low dose trials Research Report on CIT-013 low dose

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study With CIT-013 in RA Patients
CIT-013 low dose, CIT-013 high dose, Placebo - Rheumatoid Arthritis
Phase 2CompletedCitryll BV962025-07-292026-10-19

Conditions studied

Arthritis, Rheumatoid (1)

Sponsors

Citryll BV (1)

Countries

Belgium (1)  ·  Germany (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Spain (1)

Top investigators

Maarten Kraan (1)